Dutch bleeding study reveals Real-World use of reversal drug
NCT ID NCT05898412
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 32 times
Summary
This study reviewed medical records of 217 Dutch adults hospitalized with serious bleeding while taking a factor Xa inhibitor blood thinner. All patients received andexanet alfa to reverse the blood thinner's effects. Researchers aimed to describe patient characteristics and outcomes, including any blood clots that occurred within 30 days. The goal is to help doctors better understand who receives this treatment and how it works in real-world practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMORRHAGE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Amsterdam, Netherlands
Conditions
Explore the condition pages connected to this study.